• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者报告的评估长期阿片类药物治疗的伤害、疗效和滥用情况的工具的初步开发。

Initial development of patient-reported instrument assessing harm, efficacy, and misuse of long-term opioid therapy.

作者信息

Becker William C, Fiellin David A, Black Anne C, Kostovich Carol T, Kerns Robert D, Fraenkel Liana

机构信息

Department of Veterans Affairs (VA) Connecticut Healthcare System, West Haven, CT;

出版信息

J Rehabil Res Dev. 2016;53(1):127-36. doi: 10.1682/JRRD.2014.11.0285.

DOI:10.1682/JRRD.2014.11.0285
PMID:27006339
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4806533/
Abstract

Guidelines on long-term opioid therapy recommend frequent reassessment of harm, efficacy, and misuse of these potentially harmful and sometimes ineffective medications. In primary care, there is a need for a brief, patient-reported instrument. This report details the initial steps in the development of such an instrument. An interdisciplinary team of clinician-scientists performed four discrete steps in this study: (1) conceptualization of the purpose and function of the instrument, (2) assembly of an item pool, (3) expert rating on which items were most important to include in the instrument, and (4) modification of expert-selected items based on a reading level check and cognitive interviews with patients. A diverse panel of 47 subject matter experts was presented with 69 items to rate on a 1-9 scale in terms of importance for inclusion in the instrument. The panel highly rated 37 items: 8 related to harm, 4 related to efficacy, and 25 related to misuse. These 37 items were then tested for patient comprehension and modified as needed. Next steps in development will include further item reduction, testing against a gold standard, and assessment of the instrument's effect on clinical outcomes.

摘要

长期阿片类药物治疗指南建议对这些潜在有害且有时无效的药物的危害、疗效和误用情况进行频繁重新评估。在初级保健中,需要一种简短的、由患者报告的工具。本报告详细介绍了开发此类工具的初步步骤。一个由临床医生 - 科学家组成的跨学科团队在本研究中进行了四个不同的步骤:(1)确定该工具的目的和功能的概念;(2)组建项目库;(3)专家对工具中应包含的最重要项目进行评分;(4)根据阅读水平检查和对患者的认知访谈对专家选定的项目进行修改。向由47名主题专家组成的多元化小组提供了69个项目,要求他们根据对纳入该工具的重要性在1 - 9分的量表上进行评分。该小组对37个项目给予了高度评价:8个与危害相关,4个与疗效相关,25个与误用相关。然后对这37个项目进行患者理解测试,并根据需要进行修改。开发的下一步将包括进一步减少项目、对照金标准进行测试以及评估该工具对临床结果的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/203c/4806533/68f121cb718d/nihms-756244-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/203c/4806533/68f121cb718d/nihms-756244-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/203c/4806533/68f121cb718d/nihms-756244-f0001.jpg

相似文献

1
Initial development of patient-reported instrument assessing harm, efficacy, and misuse of long-term opioid therapy.患者报告的评估长期阿片类药物治疗的伤害、疗效和滥用情况的工具的初步开发。
J Rehabil Res Dev. 2016;53(1):127-36. doi: 10.1682/JRRD.2014.11.0285.
2
Efficacy of the Opioid Compliance Checklist to Monitor Chronic Pain Patients Receiving Opioid Therapy in Primary Care.阿片类药物依从性检查表在基层医疗中监测接受阿片类药物治疗的慢性疼痛患者的疗效。
J Pain. 2016 Apr;17(4):414-23. doi: 10.1016/j.jpain.2015.12.004. Epub 2015 Dec 17.
3
Management of patients with issues related to opioid safety, efficacy and/or misuse: a case series from an integrated, interdisciplinary clinic.阿片类药物安全性、有效性和/或滥用相关问题患者的管理:来自一家综合跨学科诊所的病例系列
Addict Sci Clin Pract. 2016 Jan 28;11(1):3. doi: 10.1186/s13722-016-0050-0.
4
Prescription Opioid Misuse, Abuse, Morbidity, and Mortality: Balancing Effective Pain Management and Safety.处方阿片类药物的误用、滥用、发病率和死亡率:平衡有效的疼痛管理与安全性
Pain Med. 2015 Oct;16 Suppl 1:S3-8. doi: 10.1111/pme.12904. Epub 2015 Sep 11.
5
Predicting Risk for Opioid Misuse in Chronic Pain with a Single-Item Measure of Catastrophic Thinking.用灾难性思维的单项测量法预测慢性疼痛患者阿片类药物滥用风险
J Am Board Fam Med. 2017 Nov-Dec;30(6):828-831. doi: 10.3122/jabfm.2017.06.170124.
6
Opioid prescribing is a surrogate for inadequate pain management resources.阿片类药物的处方开具是疼痛管理资源不足的一种表现。
Can Fam Physician. 2016 Jun;62(6):465-8.
7
[Long-term administration of opioids for non-tumor pain - LONTS guideline provides an orientation].[阿片类药物用于非肿瘤疼痛的长期管理——LONTS指南提供了指导]
Anasthesiol Intensivmed Notfallmed Schmerzther. 2015 Oct;50(10):606-12. doi: 10.1055/s-0041-107055. Epub 2015 Oct 28.
8
Adapting the Current Opioid Misuse Measure (COMM) for people with chronic pain and disability due to arthritis: The development of the COMM 11-PWDA.为关节炎导致慢性疼痛和残疾的人群改编当前阿片类药物滥用测量表(COMM):COMM 11-PWDA 的制定。
Disabil Health J. 2022 Jun;15(2S):101296. doi: 10.1016/j.dhjo.2022.101296. Epub 2022 Feb 26.
9
South African guideline for the use of chronic opioid therapy for chronic non-cancer pain.南非慢性非癌痛患者使用慢性阿片类药物治疗指南。
S Afr Med J. 2013 Oct 11;104(1 Suppl 1):78-89. doi: 10.7196/samj.7316.
10
Development and validation of the Current Opioid Misuse Measure.当前阿片类药物滥用测量方法的开发与验证
Pain. 2007 Jul;130(1-2):144-56. doi: 10.1016/j.pain.2007.01.014. Epub 2007 May 9.

引用本文的文献

1
Development and field testing of primary care screening tools for harms of long-term opioid therapy continuation and tapering to discontinuation: a study protocol.基层医疗中用于长期阿片类药物治疗持续和逐渐停药的危害筛查工具的开发和现场测试:一项研究方案。
BMJ Open. 2021 Oct 7;11(10):e053524. doi: 10.1136/bmjopen-2021-053524.
2
"Clues" That Patients May Be Willing to Consider Opioid Reductions.患者可能愿意考虑减少阿片类药物使用的“线索”。
J Gen Intern Med. 2020 Jun;35(6):1629-1630. doi: 10.1007/s11606-020-05712-6.

本文引用的文献

1
Opioid therapy for chronic pain in the United States: promises and perils.美国慢性疼痛的阿片类药物治疗:前景与风险。
Pain. 2013 Dec;154 Suppl 1(0 1):S94-S100. doi: 10.1016/j.pain.2013.09.009. Epub 2013 Sep 11.
2
Instruments to assess patient-reported safety, efficacy, or misuse of current opioid therapy for chronic pain: a systematic review.评估患者报告的当前用于慢性疼痛的阿片类药物治疗的安全性、疗效或滥用的工具:系统评价。
Pain. 2013 Jun;154(6):905-16. doi: 10.1016/j.pain.2013.02.031. Epub 2013 Mar 14.
3
Opioids for chronic pain: new evidence, new strategies, safe prescribing.慢性疼痛的阿片类药物治疗:新证据、新策略、安全处方。
Am J Med. 2013 Mar;126(3 Suppl 1):S3-11. doi: 10.1016/j.amjmed.2012.11.011.
4
Opioid dose and risk of road trauma in Canada: a population-based study.加拿大阿片类药物剂量与道路创伤风险:基于人群的研究。
JAMA Intern Med. 2013 Feb 11;173(3):196-201. doi: 10.1001/2013.jamainternmed.733.
5
Measuring pain impact versus pain severity using a numeric rating scale.使用数字评分量表测量疼痛的影响与严重程度。
J Gen Intern Med. 2012 May;27(5):555-60. doi: 10.1007/s11606-011-1926-z. Epub 2011 Nov 12.
6
Long-term opioid therapy reconsidered.重新考虑长期阿片类药物治疗。
Ann Intern Med. 2011 Sep 6;155(5):325-8. doi: 10.7326/0003-4819-155-5-201109060-00011.
7
Opioid analgesics and the risk of fractures in older adults with arthritis.阿片类镇痛药与老年关节炎患者骨折风险。
J Am Geriatr Soc. 2011 Mar;59(3):430-8. doi: 10.1111/j.1532-5415.2011.03318.x.
8
The patient-provider relationship in chronic pain care: providers' perspectives.慢性疼痛护理中的医患关系:提供者的观点。
Pain Med. 2010 Nov;11(11):1688-97. doi: 10.1111/j.1526-4637.2010.00980.x.
9
Reasons for under-use of prescribed opioid medications by patients in pain.疼痛患者未使用处方阿片类药物的原因。
Pain Med. 2010 Jun;11(6):861-71. doi: 10.1111/j.1526-4637.2010.00868.x.
10
FDA guidance on patient reported outcomes.美国食品药品监督管理局关于患者报告结局的指南。
BMJ. 2010 Jun 21;340:c2921. doi: 10.1136/bmj.c2921.